copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis Figure 1 Mechanism of pathogenesis in MRSA (A) S aureus gains access to the bloodstream or underlying tissues due to a breach in cutaneous or mucosal barriers (B) Colonization occurs on the endothelial layer by adhesion with the help of MSCRAMM (C) As the S aureus cells multiply, polymorphonuclear leukocytes (PMNs) are recruited, and a fibrin pseudo-capsule termed as abscess is formed with
1232. Mupirocin Susceptibility of - Oxford Academic Patients ranged in age from newborn to 94 years Twenty-four SA isolates (10 8%) were resistant to mupirocin (20 MRSA and 4 MSSA) Of the 24 MuR strains, 19 (79 2%) isolates demonstrated high-level resistance 10: January 2023: 12: February 2023: 3: March 2023: 1: April 2023: 2: May 2023: 1: June 2023: 1: This PDF is available to
A review on mechanism of action, resistance, synergism, and clinical . . . MUP-based decolonization was effective in more than half of the patients at preventing subsequent CA-MRSA skin and soft tissue infections [80] In a placebo-controlled study performed by Raz et al , MUP was used to prevent the recurrent staphylococcal nasal colonization and skin infection in 17 patients and was not used in the placebo group (17 MUP-untreated patients)
Mupirocin susceptibility of staphylococci 2022: Is it time for a change . . . In this retrospective study, 22 5% of MRSA isolates studied were mupirocin-resistant, and 3 quarters of these were highly resistant (MIC values >256mcg ml) In contrast, only 3% of MSSA strains were mupirocin-resistant Soft and or tissue and screening and or nares MRSA isolates were the most likely to be mupirocin resistant
Mupirocin enhances the biofilm formation of Staphylococcus epidermidis . . . Mupirocin, a fermentation production of Psedomonas fluorescens, acts as a protein synthesis inhibitor by binding to the isoleucyl-tRNA synthesis enzyme and hindering the insertion of isoleucine into protein This antibiotic is widely used to decolonize staphylococcal carriers and prevent certain staphylococcal infections, but the increasing trend of mupirocin resistance in clinical isolates has
Genomic adaptations of methicillin-resistant Staphylococcus aureus in . . . The rise of antibiotic resistance in MRSA is not only a clinical challenge but also reflects the coevolution of pathogens within suggesting that these antibiotics remain effective treatment options for severe MRSA infections [27] However, the emergence of vancomycin (2023), 10 3389 fmicb 2023 1204428 Google Scholar [5] G
A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis Patel and Rawat 10 3389 fmicb 2023 1204428 It is still debatable whether MRSA is more virulent than MSSA Meta-analysis results of some of the epidemiological studies have indicated increased mortality and or morbidity in the case of nosocomial MRSA infections such as those associated with surgery, pneumonia, and bloodstream, etc
A hope for ineffective antibiotics to return to treatment . . . Introduction The rise and rapid dissemination of multi-drug resistant (MDR) bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant S aureus (VRSA), have become a grave concern for the medical community These pathogens possess the ability to form biofilms, rendering them even more resilient against conventional antibiotics (Craft et al , 2019)
Antibiofilm effect of melittin alone and in combination with . . . Citation: Mirzaei R, Esmaeili Gouvarchin Ghaleh H and Ranjbar R (2023) Antibiofilm effect of melittin alone and in combination with conventional antibiotics toward strong biofilm of MDR-MRSA and -Pseudomonas aeruginosa Front Microbiol 14:1030401 doi: 10 3389 fmicb 2023 1030401 Received: 28 August 2022; Accepted: 01 February 2023;
Frontiers | Antimicrobial resistance and clonality of Staphylococcus . . . MRSA frequency ranged from less than 10% in the first decade of surveillance (2001–2010) suggest that these ready available antibiotics in our setting are still effective against S aureus Front Microbiol 14:1208131 doi: 10 3389 fmicb 2023 1208131 Received: 18 April 2023; Accepted: 04 July 2023; Published: 24 July 2023 Edited by: